The novel personalized mRNA vaccine also demonstrates the potential for such vaccines in other solid tumor types.

Stony Brook Cancer Center is one of 160 sites worldwide participating in the FLAMINGO-01 Phase III clinical trial.

Nearly all of the patients who responded to the a personalized mRNA pancreatic vaccine are still alive six years later.

A hospital on Long Island is testing a vaccine against breast cancer and is accepting patients for a clinical trial.

At a major cancer research conference in the United States, scientists have shared the latest on an experimental vaccine for ...

The treatment staved off cancer for seven of eight patients with a condition where the odds are rarely that good.

Men who got the HPV vaccine had a 46% reduction in risk of developing HPV-related cancers, a new study says. Dr. Leana Wen ...

The new trial makes mRNA vaccines personalized, taking an individual’s unique tumor cells. Seven out of the study’s eight ...

Pancreatic cancer kills roughly nine out of every ten people diagnosed with it, most within five years. So when researchers ...

A recent clinical trial using an mRNA vaccine helped to greatly extend the lives of people with pancreatic cancer and a new ...

There is some promising news for pancreatic cancer research, as medical data show lasting results from the trial of a vaccine ...

In separate clinical trials, two treatments showed promise that they could help patients with one of the most dire diagnoses ...